I.R.O. Nováková

The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability

Bert Verbruggen, I.R.O. Nováková, H. Wessels et al. · Thrombosis and Haemostasis · 1995 · 652 citations

Immunology, Pathology, M Imidazole +22

Reliability of Five Rapid D-Dimer Assays Compared to ELISA in the Exclusion of Deep Venous Thrombosis

Mirian C. H. Janssen, A E Heebels, Martin Metz et al. · Thrombosis and Haemostasis · 1997 · 131 citations

Deep Venous Thrombosis, Immunology, Diagnosis +21

Efficacy of Itraconazole in the Prevention of Fungal Infections Among Neutropenic Patients with Hematologic Malignancies and Intensive Chemotherapy. A Double Blind, Placebo Controlled Study

Gerard Vreugdenhil, Beatrix J. Van Dijke, J. Peter Donnelly et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1993 · 96 citations

Itraconazole Group, Pathology, Medicinal Fungi +16

Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy

E.F. van der Molen, Bert Verbruggen, I.R.O. Nováková et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2000 · 93 citations

The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B

J. W. van‘t Wout, I.R.O. Nováková, C.A.H.H.V.M. Verhagen et al. · Journal of Infection · 1991 · 90 citations

Antifungal Agent, Health Sciences, Antifungal Agents +9